Details for New Drug Application (NDA): 202850
✉ Email this page to a colleague
The generic ingredient in POLYETHYLENE GLYCOL 3350 is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
Summary for 202850
Tradename: | POLYETHYLENE GLYCOL 3350 |
Applicant: | Ani Pharms |
Ingredient: | polyethylene glycol 3350 |
Patents: | 0 |
Pharmacology for NDA: 202850
Mechanism of Action | Osmotic Activity |
Physiological Effect | Stimulation Large Intestine Fluid/Electrolyte Secretion |
Suppliers and Packaging for NDA: 202850
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 202850 | ANDA | ANI Pharmaceuticals, Inc. | 62559-157 | 62559-157-10 | 100 PACKET in 1 CARTON (62559-157-10) / 17 g in 1 PACKET (62559-157-17) |
POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 202850 | ANDA | ANI Pharmaceuticals, Inc. | 62559-157 | 62559-157-30 | 30 PACKET in 1 CARTON (62559-157-30) / 17 g in 1 PACKET (62559-157-17) |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | FOR SOLUTION;ORAL | Strength | 17GM/SCOOPFUL | ||||
Approval Date: | Dec 15, 2015 | TE: | RLD: | No |
Complete Access Available with Subscription